Boon For Lupin As FDA Upgrades Somerset Site Status

Stricken US Facility Handed Voluntary Action Indicated Status By FDA

manufacturing facility
Lupin must return its facilities to FDA compliance • Source: Shutterstock

More from Manufacturing

More from Business